Experienced in Plaque Psoriasis

Dr. Teresa S. Sligh

Internal Medicine
3808 W Riverside Dr, 
Burbank, CA 
Experienced in Plaque Psoriasis
3808 W Riverside Dr, 
Burbank, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Teresa Sligh is a primary care provider, practicing in Internal Medicine in Burbank, California. Dr. Sligh is rated as an Experienced provider by MediFind in the treatment of Plaque Psoriasis. Her top area of expertise is Plaque Psoriasis.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Plaque Psoriasis.

Specialties
Internal Medicine
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

3808 W Riverside Dr, Burbank, CA 91505

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2024
Intervention Type: Drug
Study Drug: Pentosan Polysulfate Sodium
Study Phase: Phase 2/Phase 3
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
Enrollment Status: Unknown
Publish Date: April 04, 2022
Intervention Type: Biological, Other
Study Drug: FB825
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Bexagliflozin in Subjects With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled by Metformin Alone
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Bexagliflozin in Subjects With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled by Metformin Alone
Enrollment Status: Completed
Publish Date: July 07, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Enrollment Status: Completed
Publish Date: May 25, 2021
Intervention Type: Drug
Study Phase: Phase 1
Randomized, Double-blind, Placebo-controlled, Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Randomized, Double-blind, Placebo-controlled, Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Enrollment Status: Completed
Publish Date: August 28, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

2 Total Publications

Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.
Journal: Clinical and translational science
Published: August 14, 2023
Similar Doctors
Experienced in Plaque Psoriasis
Dr. Azita Fakheri
Internal Medicine
Experienced in Plaque Psoriasis
Dr. Azita Fakheri
Internal Medicine
19100 Ventura Blvd, Suite A, 
Tarzana, CA 
 (12.0 miles away)
818-343-0101
Languages Spoken:
English
See accepted insurances

Azita Fakheri is a primary care provider, practicing in Internal Medicine in Tarzana, California. Dr. Fakheri is rated as an Advanced provider by MediFind in the treatment of Plaque Psoriasis. Her top areas of expertise are Perioral Dermatitis, Warts, Malignant Hypertension, and Genital Warts.

Experienced in Plaque Psoriasis
Dr. Michael Elist
Internal Medicine
Experienced in Plaque Psoriasis
Dr. Michael Elist
Internal Medicine
12922 Victory Boulevard, 
North Hollywood, CA 
 (4.8 miles away)
818-760-2800
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Elist is a primary care provider, practicing in Internal Medicine in North Hollywood, California. Dr. Elist has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Fibromyalgia, Psoriatic Arthritis, Osteoarthritis, and Scleroma. Dr. Elist is currently accepting new patients.

Experienced in Plaque Psoriasis
Dr. James W. Lee
Internal Medicine
Experienced in Plaque Psoriasis
Dr. James W. Lee
Internal Medicine
1510 S Central Ave, Suite 540, 
Glendale, CA 
 (5.1 miles away)
818-553-1106
Languages Spoken:
English
See accepted insurances
Offers Telehealth

James Lee is a primary care provider, practicing in Internal Medicine in Glendale, California. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Alzheimer's Disease, Sideroblastic Anemia, Non-Small Cell Lung Cancer (NSCLC), Gastrostomy, and Cardiac Ablation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sligh's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile